Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break

Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break

Patients with idiopathic pulmonary fibrosis are screened for circulating autoantibodies as part of the initial interstitial lung disease workup. Management of seropositive idiopathic pulmonary fibrosis is currently considered no different than that of lone idiopathic pulmonary fibrosis. Emerging dat...

Full description

Bibliographic Details
Main Authors: Paraskevi Kirgou, Sotirios I. Sinis, Ilias E. Dimeas, Ilias C. Papanikolaou, Konstantinos Tatsis, Athena Gogali, Konstantinos I. Gourgoulianis, Dimitrios P. Bogdanos, Zoe Daniil
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Medicine
Subjects:
idiopathic pulmonary fibrosis
autoimmunity
antinuclear antibody
autoantibodies
interstitial lung disease
pulmonary function test (PFTs)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.964722/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.964722/full

Similar Items